Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer

Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer

US Patent 11000518 · Granted May 11, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfonylurea derivative and medical uses thereof2025
Humanized monoclonal antibody targeting BCMA and having human monkey cross-react2025
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of d2025
Cyclic molecules as Bruton's tyrosine kinase inhibitor2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use2025
Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use2025
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application2024